Integrated mimicry of B cell antibody mutagenesis using yeast homologous recombination.

Molecular Biotechnology
Jeffrey S SwersK Dane Wittrup

Abstract

Antibody affinity maturation proceeds in vivo via a combination of point mutations, insertions, deletions, and combinatorial shuffling of light chains or portions of the heavy chain, thereby reducing the probability of trapping in local affinity optima in sequence space. In vivo homologous recombination in yeast can be exploited to mimic the broad spectrum of mutational types deployed by B cells, incorporating both receptor revision and receptor editing together with polymerase-directed point mutagenesis. This method was used to effect a 10,000-fold affinity improvement in an anti-peptide single-chain antibody in three rounds of mutagenesis and screening, and a 1,000-fold affinity improvement in an anti-protein single-chain antibody in a single round. When recombinational mutagenesis (CDR or chain shuffling) was directly compared to error-prone PCR, the recombinational approach yielded greater affinity improvement with substantially reduced divergence from germline sequences, demonstrating an advantage of simultaneously testing a broad range of mutational strategies.

References

Mar 15, 1996·Journal of Molecular Biology·I M TomlinsonG Winter
Jun 1, 1997·Nature Biotechnology·E T Boder, K D Wittrup
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·J HanesA Plückthun
Apr 22, 1999·Immunology Today·A J George, D Gray
Dec 28, 1999·Journal of Molecular Biology·R M de WildtI M Tomlinson
Jan 14, 2000·Nature Biotechnology·D Sblattero, A Bradbury
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·P S DaughertyG Georgiou
Jun 6, 2000·The Journal of Experimental Medicine·D Nemazee, M Weigert
Jun 6, 2000·The Journal of Experimental Medicine·P C WilsonJ D Capra
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·E T BoderK D Wittrup
Feb 27, 2001·Science·R CasellasM C Nussenzweig
Mar 29, 2002·European Journal of Immunology·Masaki MagariHitoshi Ohmori
Sep 11, 2002·Molecular Immunology·Peter EllmarkMats Ohlin
Dec 18, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jane Seagal, Doron Melamed
Mar 14, 2003·Current Opinion in Immunology·David Nemazee, Kristin A Hogquist
Oct 24, 2003·Trends in Biotechnology·Lucy J HoltIan M Tomlinson
Jan 28, 2004·Cell·David Jung, Frederick W Alt
Feb 24, 2004·Nucleic Acids Research·Jeffrey S SwersK Dane Wittrup
Aug 4, 2004·Methods in Enzymology·David W ColbyK Dane Wittrup
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·W P Jencks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.